Tetra Radar · FDA Approvals · Decision date

povetacicept: FDA decision date

Zai Lab Ltd (ZLAB) · 30 November 2026

Povetacicept (Pove, Anti-APRIL/BAFF): In June 2026, our partner Vertex announced that the FDA accepted its BLA submission for pove for accelerated approval in adults with IgAN, with a PDUFA target action date of November 30, 2026.

Source: 10-Q of 6 August 2026

The decision is pending.

Zai Lab Ltd on Tetra Radar

A PDUFA date is the date by which the FDA has said it will decide on an application. Dates can move, and a decision is not an approval. Tetra Radar observes public information for research purposes. It does not provide investment advice.

Get the Dispatch free.